COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 2050: Articles 20491-20500  | Next

COVID-19: how the pandemic impacted the emergency department and urgent surgical activity in a medium-size Italian hospital.
Pinotti, E., Carissimi, F., Baronio, G., Montuori, M., Ongaro, D., Ciocca Vasino, M.
10.1101/2020.11.19.20234856 — Posted: 2020-11-20
IMPACT OF THE CORONAVIRUS DISEASE 2019 PANDEMIC ON SURGICAL VOLUME IN JAPAN: A COHORT STUDY USING ADMINISTRATIVE DATA
Okuno, T., Takada, D., Jung-ho, S., Morishita, T., Itoshima, H., Kunisawa, S., Imanaka, Y.
10.1101/2020.11.18.20233882 — Posted: 2020-11-20
Impact of the home confinement related to COVID-19 on the device-assessed physical activity and sedentary patterns of Spanish older adults
Fernandez-Garcia, A. I., Marin-Puyalto, J., Gomez-Cabello, A. M., Matute-Llorente, A., Subias-Perie, J., Perez-Gomez, J., Lozano-Berges, G., Manas, A., Guadalupe-Grau, A., Gonzalez-Gross, M., Ara, I., Casajus, J. A., Vicente-Rodriguez, G.
10.1101/2020.11.19.20234583 — Posted: 2020-11-20
Clinical evaluation of the Roche/SD Biosensor rapid antigen test with symptomatic, non-hospitalized patients in a municipal health service drive-through testing site.
Igloi, Z., Velzing, J., van Beek, J., van de Vijver, D., Aron, G., Ensing, R., Benschop, K., Han, W., Boelsums, T., Koopmans, M., Geurtsvankessel, C., Molenkamp, R.
10.1101/2020.11.18.20234104 — Posted: 2020-11-20 Discussion: Onsite
A network modelling approach to assess non-pharmaceutical disease controls in a worker population: An application to SARS-CoV-2
Hill, E. M., Atkins, B. D., Keeling, M. J., Dyson, L., Tildesley, M. J.
10.1101/2020.11.18.20230649 — Posted: 2020-11-20
Multicenter evaluation of the Panbio COVID-19 Rapid Antigen-Detection Test for the diagnosis of SARS-CoV-2 infection
Merino-Amador, P., Guinea, J., Munoz-Gallego, I., Gonzalez-Donapetry, P., Galan, J. C., Antona, N., Cilla, G., Hernaez-Crespo, S., Diaz-de Tuesta, J.-L., Gual-de Torrella, A., Gonzalez-Romo, F., Escribano, P., Sanchez-Castellano, M. A., Sota-Busselo, M., Delgado-Iribarren, A., Garcia, J., Canton, R., Munoz, P., Folgueira, D., Cuenca-Estrella, M., Oteo-Iglesias, J., Spanish Panbio COVID-19 validation group
10.1101/2020.11.18.20230375 — Posted: 2020-11-20
The potential impact of School Closure Relative to Community-based Non-pharmaceutical Interventions on COVID-19 Cases in Ontario, Canada
Naimark, D. M., Mishra, S., Barrett, K., Khan, Y., Mac, S., Ximenes, R., Sander, B.
10.1101/2020.11.18.20234351 — Posted: 2020-11-20
Prolonged presence of replication-competent SARS-CoV-2 in mildly symptomatic individuals: A Report of 2 Cases
Mendes-Correa, M. C., Leal, F. E., Villas-Boas, L. S., Witkin, S. S., de Paula, A., Tozetto-Mendoza, T. R., Ferreira, N. E., Curty, G., de Carvalho, P. S., Buss, L. F., Costa, S. F., Carvalho, F. M. d. C., Kawakami, J., Taniwaki, N. N., Paiao, H., Bizario, J. C. d. S., de Jesus, J. G., Sabino, E. C., Romano, C. M., Grepan, R. M. Z., Sesso, A.
10.1101/2020.11.18.20232546 — Posted: 2020-11-20
Effectiveness of remdesivir with and without dexamethasone in hospitalized patients with COVID-19
Garibaldi, B. T., Wang, K., Robinson, M. L., Zeger, S. L., Bandeen Roche, K., Wang, M.-C., Alexander, G. C., Gupta, A., Bollinger, R., Xu, Y.
10.1101/2020.11.19.20234153 — Posted: 2020-11-20
Mortality rates in matched cohort, pseudo-randomised and randomised trials of convalescent plasma given to COVID-19 patients.
Ahmad, A., Salsabil, M., Oliver, T.
10.1101/2020.11.19.20234757 — Posted: 2020-11-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).